Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
natalizumab (tysabri) (1 trial)
Myositis (Phase 1)
Myositis, Inclusion Body (Phase 1)
Trials (1 total)
Trial APIs (1 total)